Navigated Transcranial Magnetic Stimulation (nTMS) for Preoperative Brain Mapping
This policy addresses coverage and medical policy stance for navigated transcranial magnetic stimulation (nTMS) used as a noninvasive preoperative cortical mapping technique (motor and language) for patients with brain lesions considered for surgical resection. It applies to Blue Cross Blue Shield - Rhode Island products (BlueCHiP for Medicare and Commercial).
No material clinical or coverage changes in this revision.
Coverage Determination for Navigated Transcranial Magnetic Stimulation (nTMS)
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.